Sign In
Buy CAPR
$25.33
-0.680 (-2.61%)
At Close: Jun 10, 2026
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.21%
12:00am, Wednesday, 29'th Apr 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.21%
Did You Manage To Avoid Capricor Therapeutics' (NASDAQ:CAPR) 97% Share Price Wipe Out?
11:31am, Friday, 24'th Apr 2020
Capricor Therapeutics, Inc. (NASDAQ:CAPR) shareholders should be happy to see the share price up 27% in the last week...
Capricor Therapeutics to Host Key Opinion Leader Call on Cardiac Complications of Duchenne Muscular Dystrophy
01:00pm, Monday, 13'th Apr 2020
Capricor Therapeutics (CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment or prevention of serious diseases, today anno
15 Healthcare Stocks Moving In Tuesday's Pre-Market Session
11:38am, Tuesday, 07'th Apr 2020
Gainers
• Sangamo Therapeutics, Inc. (NASDAQ:SGMO) stock moved upwards by 7.24% to $7.26 during Tuesday's pre-market session.
• Capricor Therapeutics, Inc. (NASDAQ:...
This Penny Stock Joins the Fight Against Coronavirus; Analyst Sees Triple-Digit Upside
08:02pm, Monday, 06'th Apr 2020
With a market cap of a miniscule $10.16 million, you can firmly place biotech Capricor Therapeutics (CAPR) in the nano cap section. Although, according to one analyst, if recent developments are anyth
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:16am, Monday, 06'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InspireMD (NSPR), IDEAYA Biosciences (IDYA) and Capricor
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:15am, Monday, 06'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on InspireMD (NSPR
TSLA, ET among premarket gainers
01:21pm, Friday, 03'rd Apr 2020
Capricor Therapeutics (NASDAQ:CAPR) +26% on providing its CAP-1002 cell therapy under compassionate use for patients with advanced COVID-19.Fate Therapeutics (NASDAQ:FATE) +19% on J&J cell therapy
Shipping begins for Aytu rapid blood test - COVID-19 updates
12:14pm, Friday, 03'rd Apr 2020
Aytu BioScience (NASDAQ:AYTU) has begun shipping its rapid antibody blood test for COVID-19. Shares up 8% premarket.Stryker (NYSE:SYK) has developed a low-cost limited-release emergency response bed
Capricor Initiates Compassionate Use Program for Severe COVID-19 Patients using CAP-1002, its Novel Cell Therapy
12:00pm, Friday, 03'rd Apr 2020
Capricor Therapeutics (CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment or prevention of serious diseases, today anno
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abeona Therapeutics (ABEO), Teva Pharmaceutical Industries (TEVA) and
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Abeona Therapeutics (
ABEO
–
Research Report
), Teva Pharmaceutical Industries (
TEVA
–
Research Report
) and Capr
CCL, RBS among premarket losers
01:22pm, Friday, 27'th Mar 2020
Arlington Asset Investment (NYSE:AI) -21% after suspending Q1 dividend.BGC Partners (NASDAQ:BGCP) -20% on dividend cut.Altimmune (NASDAQ:ALT) -15% on FY earnings.Arbutus Biopharma (NASDAQ:ABUS)�
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 6.38%
12:00am, Thursday, 26'th Mar 2020
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 6.38%
Capricor Therapeutics to Host a Key Opinion Leader Call On Why Exosomes are Uniquely Suited for Vaccine Development
12:00pm, Tuesday, 24'th Mar 2020
Capricor Therapeutics (CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and oth
